Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5918028
Reference Type
Journal Article
Title
The determination of delta-5-androstenediol and its sulphate in serum and urine by gas chromatography-mass spectrometry
Author(s)
Dikkeschei, LD; Wolthers, BG; Willemse, PH; van der Pol, H; de Ruyter-Buitenhuis, AW; Nagel, GT
Year
1993
Is Peer Reviewed?
Yes
Journal
Clinical Endocrinology
ISSN:
0300-0664
EISSN:
1365-2265
Volume
39
Issue
4
Page Numbers
469-474
Language
English
PMID
8287574
DOI
10.1111/j.1365-2265.1993.tb02395.x
Web of Science Id
WOS:A1993MA08800013
Abstract
OBJECTIVES:
We developed an assay for delta-5-androstenediol (adiol) and delta-5-androstenediol-3-sulphate (adiol-3S) in serum and adiol and total adiol sulphate (adiol-S) in urine.
DESIGN:
An analytical procedure using HPLC and gas chromatography-mass spectrometry was devised and tested for its reliability.
MEASUREMENTS:
After addition of deuterated androstenediol as internal standard, serum and urine samples were extracted. Steroid sulphates were hydrolysed. The extracts and hydrolysates were purified on HPLC, adiol was derivatized using heptafluorobutyric anhydride and finally quantified by gas chromatography-mass spectrometry.
RESULTS:
The assay is accurate and reproducible. The coefficient of variation (CV) for the determination of adiol in serum samples is 4% (intra-assay) and 9% (interassay) and for urine samples 3 and 8% respectively. The intra-assay CV for the adiol-3S analyses is 5% for serum and 2% for urine samples while the interassay CV values for adiol-3S are 10% for serum and 7% for urine samples. The recovery of adiol and adiol-3S from serum and urine samples is 97%.
CONCLUSIONS:
The developed assay meets the analytical demands needed for clinical applications.
Tags
PFAS
•
Additional PFAS (formerly XAgency)
•
Expanded PFAS SEM (formerly PFAS 430)
Litsearch: September 2019
PubMed
Web of Science
Not prioritized for screening
Heptafluorobutanoic anhydride
Perfluorobutanoic anhydride
•
PFAS Universe
Data Source
Web of Science
Pubmed
Perfluorobutanoic anhydride
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity